Biblio Discovery — Demo Discovery Service

191 results for "SAAG, KENNETH G."

Showing 1–20 · 1.11 seconds · RSS

  1. Journal Article Full text

    GLUCOCORTICOIDS IN CHRONIC DISEASE: THE GOOD, THE BAD, THE BONE

    Saag, Kenneth G.

    Trans Am Clin Climatol Assoc · 2023 · English · PubMed Central

    Despite the advent of more targeted therapies, glucocorticoids (steroids) remain in chronic use (defined as > 3 months or more) by an estimated 0.5% of the population. Steroids yield symptomatic benefits for systemic and local inflammation as well as disease-modifying properties in rheumatoid…

  2. Journal Article Full text

    Prevention and Treatment of Bone Changes Associated with Exposure to Glucocorticoids

    Warriner, Amy; Saag, Kenneth G

    Curr Osteoporos Rep · 2013 · English · PubMed Central

    Rheumatologic diseases are associated with a pro-inflammatory state which is thought to lead to many of the bone changes seen in treatment-naive patients. However, glucocorticoids remain a common treatment option for rheumatologic diseases and are known to have a negative impact on bone through…

  3. Journal Article Full text

    Epidemiology, risk factors, and lifestyle modifications for gout

    Saag, Kenneth G; Choi, Hyon

    Arthritis Res Ther · 2006 · English · PubMed Central

    Gout affects more than 1% of adults in the USA, and it is the most common form of inflammatory arthritis among men. Accumulating data support an increase in the prevalence of gout that is potentially attributable to recent shifts in diet and lifestyle, improved medical care, and increased…

  4. Journal Article Full text

    Progress in osteoporosis and fracture prevention: focus on postmenopausal women

    Saag, Kenneth G; Geusens, Piet

    Arthritis Res Ther · 2009 · English · PubMed Central

    In the past decade, we have witnessed a revolution in osteoporosis diagnosis and therapeutics. This includes enhanced understanding of basic bone biology, recognizing the severe consequences of fractures in terms of morbidity and short-term re-fracture and mortality risk and case finding based on…

  5. Journal Article Full text

    Expert Perspective: How, When, and Why to Potentially Stop Antiresorptive Drugs in Osteoporosis

    Adami, Giovanni; Saag, Kenneth G.

    Arthritis Rheumatol · 2025 · English · PubMed Central

    Osteoporosis is a chronic disease, and antiresorptive treatments are often continued for many years. Despite their established efficacy in reducing fracture risk, the most commonly used antiresorptive treatments, bisphosphonates and denosumab, have short‐ and long‐term risks that, coupled with…

  6. Journal Article Full text

    Febuxostat: the evidence for its use in the treatment of hyperuricemia and gout

    Gaffo, Angelo L; Saag, Kenneth G

    Core Evid · 2010 · English · PubMed Central

    INTRODUCTION: Gout is a common and disabling cause of arthritis in middle-aged and elderly populations, with its main predisposing factor being hyperuricemia (serum urate > 6.8 mg/dL). Options for treatment of chronic gout until 2008 were allopurinol, a xanthine oxidase inhibitor, and the group of…

  7. Journal Article Full text

    Serum urate, menopause, and postmenopausal hormone use: from eminence to evidence-based medicine

    Gaffo, Angelo L; Saag, Kenneth G

    Arthritis Res Ther · 2008 · English · PubMed Central

    The relationship between serum urate, menopause, and aging has not been clearly defined by scientific evidence. In the present issue of Arthritis Research and Therapy, Hak and Choi present a cross-sectional analysis to clarify the effect of menopause and hormone replacement therapy on serum urate…

  8. Journal Article Full text

    Anabolics in the management of glucocorticoid-induced osteoporosis: an evidence-based review of long-term safety, efficacy and place in therapy

    Taylor, Adam D; Saag, Kenneth G

    Core Evid · 2019 · English · PubMed Central

    INTRODUCTION: Glucocorticoid-induced osteoporosis is an underrecognized complication of chronic glucocorticoid therapy characterized by a decrease in new bone formation. Anabolic therapies, such as teriparatide, a recombinant human parathyroid hormone, combat the disease by promoting new bone…

  9. Journal Article Full text

    Osteoporotic fractures in older adults

    Colón-Emeric, Cathleen S.; Saag, Kenneth G.

    Best Pract Res Clin Rheumatol · 2006 · English · PubMed Central

    Osteoporotic fractures are emerging as a major public health problem in the aging population. Fractures result in increased morbidity, mortality and health expenditures. This article reviews current evidence for the management of common issues following osteoporotic fractures in older adults…

  10. Journal Article Full text

    Healthcare Providers' Recommendations for Physical Activity among US Arthritis Population: A Cross-Sectional Analysis by Race/Ethnicity

    Austin, Shamly; Saag, Kenneth G.; Pisu, Maria

    Arthritis · 2018 · English · PubMed Central

    INTRODUCTION: We examined racial/ethnic disparities in healthcare providers' recommendations for physical activity among individuals with arthritis and evaluated this association among groups of individuals who adhered to physical activity guidelines and those who did not. METHODS: With a…

  11. Journal Article Full text

    Glucocorticoid-induced osteoporosis: from clinical trials to clinical practice

    Adami, Giovanni; Rahn, Elizabeth J; Saag, Kenneth G

    Ther Adv Musculoskelet Dis · 2019 · English · PubMed Central

    Glucocorticoid-induced osteoporosis (GIOP) is the most common form of secondary osteoporosis. To date, six large randomized controlled clinical trials on the efficacy of pharmaceutical treatment in GIOP have been conducted. All of these studies have focused predominately on bone mineral density…

  12. Journal Article Full text

    Improving drug adherence in osteoporosis: an update on more recent studies

    Jaleel, Ayesha; Saag, Kenneth G.; Danila, Maria I.

    Ther Adv Musculoskelet Dis · 2018 · English · PubMed Central

    Similar to other chronic diseases such as diabetes and hypertension, osteoporosis has struggled with suboptimal medication adherence, resulting in an increased risk of fractures and all-cause mortality. The goal of this narrative review was to summarize interventions to improve medication adherence…

  13. Journal Article Full text

    Long-term Safety Concerns of Antiresorptive Therapy

    Zhang, Jie; Saag, Kenneth G.; Curtis, Jeffrey R.

    Rheum Dis Clin North Am · 2011 · English · PubMed Central

    Bisphosphonates prevent the loss of bone mineral content by inhibiting bone resorption. As a result, bone turnover is decreased and bone mineral density maintained or even increased. Currently, bisphosphonates account for approximately 80% of all medications prescribed for osteoporosis.(1) Although…

  14. Journal Article Full text

    Factors influencing the effectiveness of allopurinol in achieving and sustaining target serum urate in the national Veterans Administration gout cohort

    Singh, Jasvinder A.; Yang, Shuo; Saag, Kenneth G.

    J Rheumatol · 2019 · English · PubMed Central

    OBJECTIVE: To assess factors associated with the ability to achieve and maintain target serum urate (SU) with allopurinol in patients with gout. METHODS: We used National VA national databases from 2002-2012. Eligible patients had ≥1 inpatient or ≥2 outpatient visits with a diagnostic code for…

  15. Journal Article Full text

    Mortality and osteoporotic fractures: is the link causal, and is it modifiable?

    Teng, Gim Gee; Curtis, effrey R.; Saag, Kenneth G.

    Clin Exp Rheumatol · 2008 · English · PubMed Central

    Osteoporosis is a global problem with an expected increase in f acture prevalence and public health burden as the world s population ages. Although excess mortality is well-described in those with low bone mineral density as well as those with recent hip and vertebral fractures, some uncertainty…

  16. Journal Article Full text

    Gout. Hyperuricemia and cardiovascular disease: how strong is the evidence for a causal link?

    Gaffo, Angelo L; Edwards, N Lawrence; Saag, Kenneth G

    Arthritis Res Ther · 2009 · English · PubMed Central

    An association between high levels of serum urate and cardiovascular disease has been proposed for many decades. However, it was only recently that compelling basic science data, small clinical trials, and epidemiological studies have provided support to the idea of a true causal effect. In this…

  17. Journal Article Full text

    Is there a role for cherries in the management of gout?

    Collins, Marcum W.; Saag, Kenneth G.; Singh, Jasvinder A.

    Ther Adv Musculoskelet Dis · 2019 · English · PubMed Central

    Despite the availability of effective urate-lowering therapy (ULT) and anti-inflammatory drugs for the treatment of gout, there is considerable interest in novel treatment approaches. Patients with gout often have a multitude of comorbidities, leading to concern over drug–drug interactions and…

  18. Journal Article Full text

    Hypophosphatemia in the setting of metabolic bone disease: case reports and diagnostic algorithm

    Day, Alvin Lee; Morgan, Sarah L.; Saag, Kenneth G.

    Ther Adv Musculoskelet Dis · 2018 · English · PubMed Central

    Osteoporosis is the most commonly encountered metabolic bone disease, and metabolic bone-disease clinics have been established to assist in the diagnosis and treatment of uncommon causes of low bone-mineral density. Hypophosphatemia leading to metabolic bone disease may be encountered, and an…